Kasauli Man Held For Trading In Spurious Pharma Raw Material

Solan : A case of spurious pharmaceutical raw material trading has come to light in Baddi where the officials of the Drugs Control Administration (DCA) arrested one Harish Kumar, a resident of Piplata village in Kasauli tehsil.

He was working for a Barotiwala-based firm which sold spurious raw material to renowned pharmaceutical firms in various parts of Himachal. Kumar was arrested under section 17(B) of the Drugs and Cosmetics Act by the officials of the DCA on May 11.

As per the information, the staff of the erring firm had affixed labels of branded companies over substandard locally available excipients, which are pharmaceutical raw materials, to make a fast buck. Excipients are inert pharmaceutical ingredients which do not have any therapeutic value in a drug.

Harish Kumar has been sent to judicial custody after completion of his police custody, confirmed DSP Baddi, Priyank Gupta.

The officials of the DCA were maintaining silence over the issue. Despite calling the drug inspectors, who have been inquiring into the case for the last four days as well as the drugs licensing authorities, none was ready to divulge any information. It is learnt that the firm owners were yet to be arrested. A team of drug inspectors and an assistant drugs controller was raiding various premises where raw material had been traded by the said firm.

The firm had been trading such raw material to various industrial clusters like Kala Amb, Paonta Sahib as well as Baddi-Barotiwala-Nalagarh industrial hub for the past several months.

Deputy Drugs Controller, Manish Kapoor, confirmed that the field staff was enquiring into a case of substandard raw material for the last four days. He said the final report was awaited from the staff.

The pharmaceutical raw material traders are granted license under the Drugs and Cosmetics Act. The use of substandard raw material has been seen as a major reason behind manufacturing of sub-standard drugs.

The case has once again exposed the proliferating substandard raw material trade in the region.

  • Related Posts

    • Pharma
    • February 10, 2025
    • 92 views
    DGFT Amends Standard Input Output Norms For Erythromycin Stearate Tablets

    Mumbai:  The Directorate General of Foreign Trade (DGFT), under the ministry of commerce & industry, has announced amendments to the Standard Input Output Norms (SION) for the export of erythromycin…

    • Pharma
    • February 10, 2025
    • 96 views
    CSIR-NIIST Develops Technology To Convert Biomedical Waste Into Soil Additives

    THIRUVANANTHAPURAM: CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) in Thiruvananthapuram has developed a technology that converts pathogenic biomedical waste into value-added soil additives that eliminate the need for costly…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    An Index To Gauge States For Drug Enforcement, Improve Drug Quality

    An Index To Gauge States For Drug Enforcement, Improve Drug Quality

    DGFT Amends Standard Input Output Norms For Erythromycin Stearate Tablets

    DGFT Amends Standard Input Output Norms For Erythromycin Stearate Tablets

    CSIR-NIIST Develops Technology To Convert Biomedical Waste Into Soil Additives

    CSIR-NIIST Develops Technology To Convert Biomedical Waste Into Soil Additives

    As Always Ahead of Game in healthcare, Doc was first to vote too

    As Always Ahead of Game in healthcare, Doc was first to vote too

    Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

    Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

    Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

    Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister